Bernstein said Novo Nordisk (NVO) study results that showed certain Rybelsus users had a 14% risk reduction for major ...

WEIGHT-LOSS jabs are the most talked about drugs of the moment. And with new studies popping up almost every week revealing ...

A late-stage study shows that Novo Nordisk's oral semaglutide, Rybelsus, cuts the risk of MACE by 14% in T2D patients ...

The agency posted documents this week that the drugmaker had requested the drug be placed on the FDA's "Demonstrable ...

There are a few. Ozempic and other semaglutide medications can come with uncomfortable side effects —like nausea, diarrhea, ...

The retrospective study points to fewer suicidal thoughts or attempts among adolescents taking semaglutide or liraglutide.

Research hints that medications like Zepbound and Wegovy could provide new ways to treat opioid and alcohol abuse.

If you’ve listened to any weight-loss podcasts or watched the news in the past year, you’ve probably heard of the new drugs: ...

Many people use semaglutides like Ozempic for weight loss, but can you use it to lose a small amount—say, 10 or 20 pounds?

The oral semaglutide reduced the occurrence of major adverse cardiovascular events (MACE) by 14% in patients with T2D.

SURVEY SAYS: Just 18% of the health-care plans sponsored by employers with 200 workers or more cover such drugs, according to ...

You’ve probably heard the chatter about injectable weight-loss medications and found yourself wondering if they might hold ...